Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus
- 1 November 2001
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 88 (10), 1201-1203
- https://doi.org/10.1016/s0002-9149(01)02063-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Novel Mechanism for Endothelial DysfunctionCirculation, 1999
- Endogenous Nitric Oxide Synthase InhibitorCirculation, 1999
- Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan‐induced hyperglycaemiaBritish Journal of Pharmacology, 1999
- Atherosclerosis — An Inflammatory DiseaseThe New England Journal of Medicine, 1999
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial DysfunctionCirculation, 1998
- Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusJournal of the American College of Cardiology, 1996
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM PatientsDiabetes Care, 1990
- Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosisMetabolism, 1987